Effects of ceramide on the Golgi stability

Download PDF
7 downloads 0 Views 570KB Size Report
Comment
Concomitant with transport block, the trans-Golgi region becomes dilated (Linardic et al., 1996), and large distended saccules, often containing other membrane- ...
3299

Journal of Cell Science 113, 3299-3307 (2000) Printed in Great Britain © The Company of Biologists Limited 2000 JCS1674

Implication of sphingolipid metabolism in the stability of the Golgi apparatus Takuya Fukunaga1, Masami Nagahama1, Kiyotaka Hatsuzawa1, Katsuko Tani1, Akitsugu Yamamoto2 and Mitsuo Tagaya1,* 1School of Life Science, Tokyo University of 2Department of Physiology, Kansai Medical

Pharmacy and Life Science, Hachioji, Tokyo 192-0392, Japan University, Moriguchi, Osaka 570-8506, Japan

*Author for correspondence (e-mail: [email protected])

Accepted 3 July 2000; published on WWW 22 August

SUMMARY We examined the effects of short chain and long chain ceramides on the stability of the Golgi apparatus. Short chain ceramides, C2- and C6-ceramides, blocked brefeldin A-induced Golgi disassembly without affecting the rapid release of Golgi coat proteins, whereas they did not inhibit brefeldin A-induced tubulation of endosomes. Both short chain ceramides also retarded Golgi disassembly induced by nordihydroguaiaretic acid and nocodazole, suggesting that they stabilize the Golgi apparatus. In contrast to short

chain ceramides, natural long chain ceramides, when incorporated into cells or formed within cells upon treatment with sphingomyelinase or metabolic inhibitors, enhanced brefeldin A-induced Golgi disassembly. These results suggest that sphingolipid metabolism is implicated in the stability of the Golgi apparatus.

INTRODUCTION

Helms and Rothman, 1992). This release leads to Golgi disassembly in an N-ethylmaleimide-sensitive factordependent manner (Fukunaga et al., 1998) and promotes the redistribution of Golgi membranes and components such as mannosidase II (Man II) into the ER (Klausner et al., 1992). Besides the effect on the nucleotide exchange on ARF, BFA inactivates CtBP/BARS, an inhibitor protein of the BFAinduced tubulation of the Golgi apparatus, by promoting its ADP-ribosylation (Spanfo et al., 1999). CtBP/BARS catalyzes the transfer of the acyl moiety of acyl-CoA to lysophosphatidic acid, an inverted cone-shaped lipid, to produce phosphatidic acid, a cone-shaped lipid. This conversion in lipid shape appears to promote fission of Golgi membranes (Weigert et al., 1999). A previous paper reported that C6-ceramide does not inhibit BFA-induced Golgi disassembly (Kok et al., 1998). When this paper appeared, we found that short chain ceramides inhibit BFA-induced Golgi disassembly. We extended our study toward gaining insight into the role of sphingolipid metabolism for the regulation of the Golgi structure. We found that, in contrast to short chain ceramides, natural long chain ceramides enhance BFA-induced Golgi disassembly. Our results suggest that ceramide is a factor that controls the stability of the Golgi apparatus.

Ceramide causes a variety of cellular processes including differentiation and apoptosis (Kolesnick and Kronke, 1998). It is synthesized in the endoplasmic reticulum (ER) and transported to the Golgi apparatus via an ATP-dependent pathway distinct from that for secretory proteins (Fukasawa et al., 1999). In the Golgi apparatus, ceramide is converted to sphingomyelin and glucosylceramide, which are then predominantly delivered to the plasma membrane (Hoekstra and Kok, 1992; Rosenwald and Pagano, 1993a; van Meer, 1993). Upon stimulation of cells, ceramide is regenerated by the action of sphingomyelinases (Hannun, 1994). Exogenously added short chain ceramide is rapidly incorporated into cells and accumulates in the Golgi apparatus (Lipsky and Pagano, 1985). The accumulation causes almost complete inhibition of protein transport at the level of the transGolgi region, whereas it slightly retards protein transport from the ER to the medial-Golgi region (Rosenwald and Pagano, 1993b). Concomitant with transport block, the trans-Golgi region becomes dilated (Linardic et al., 1996), and large distended saccules, often containing other membrane-bound structures within them, are generated (Rosenwald and Pagano, 1993b). Short chain ceramide inhibits not only constitutive transport but also the regulated secretion of amylase from pancreatic acini (Shinkai et al., 1997). In addition to these effects on the exocytotic pathways, C6-ceramide partially inhibits the endocytic pathways (Chen et al., 1995; Li et al., 1999). Brefeldin A (BFA) is a fungal metabolite that induces the rapid release of COP I from the Golgi apparatus by inhibiting the GDP-GTP exchange on ARF1 (Donaldson et al., 1992;

Key words: Brefeldin A, Ceramide, Golgi apparatus, Nocodazole, Nordihydroguaiaretic acid, Sphingomyelinase

MATERIALS AND METHODS Materials BFA, C2-ceramide, C6-ceramide and bovine brain ceramides were obtained from Wako Chemicals. Nocodazole, N-oleoylethanolamine (NOE) and sphingomyelinase from Staphylococcus aureus were

3300 T. Fukunaga and others obtained from Sigma. Sphingosine, D, L-threo-1-phenyl-2decanoylamino-3-morpholino-1-propanol (PDMP), D-erythro-C16ceramide and nordihydroguaiaretic acid (NDGA) were obtained from Biomol. Fluorescein-conjugated transferrin (Tf) was obtained from Molecular Probes. Antibodies Monoclonal antibodies against Man II and TGN38 were obtained from BAbCo and Affinity Bioreagents, respectively. A polyclonal anti-Tf antibody was obtained from Dako. A polyclonal anti-β-COP antibody was a generous gift from Dr Yamaguchi of this laboratory. Microscopy Immunofluorescence and electron microscopic analyses were performed as described by Tagaya et al. (1996) and Yamaguchi et al. (1997), respectively. A conventional fluorescence microscope was used to examine the localization of Man II because this apparatus was more suitable for obtaining image for diffused patterns of Man II than a confocal microscope. To investigate the localization of TGN38 and Tf, confocal immunofluorescence microscopy was performed with an Olympus Fluoview 300 laser scanning microscope. Cell culture NRK cells obtained from the Riken Cell Bank were grown on glass coverslips in α-minimum essential medium supplemented with 50 i.u./ml penicillin, 50 µg/ml streptomycin, and 10% fetal calf serum in a humidified atmosphere containing 5% CO2 at 37°C. Solubilization of long chain ceramides D-erythro-C16-ceramide and bovine brain ceramides were dissolved in ethanol/dodecane (98:2, v/v) at a concentration of 5 mg/ml, and then directly added to the medium. The final concentrations of ethanol and dodecane in the medium were 0.5% and 0.01%, respectively.

RESULTS Effects of short chain ceramides on BFA-induced Golgi disassembly We first examined the effects of short chain ceramides on BFA-induced Golgi disassembly. NRK cells were preincubated for 30 minutes in the absence or presence of 5 µM C6- or C2-ceramide, and then 10 µM BFA was added and the incubation was continued for 6 minutes. After fixation of cells with paraformaldehyde, both Man II, a medial-Golgi marker protein (Kornfeld and Kornfeld, 1985) and β-COP, a subunit of COPI (Waters et al., 1991), were visualized by fluorescence microscopy. In control cells Man II was localized at the perinuclear region with a ribbon-like structure (Fig. 1A). Upon BFA treatment, Man II was redistributed into the ER in almost all cells (Fig. 1C). In contrast, it was discernible at the perinuclear region when cells were incubated with C6ceramide (Fig. 1E) or C2-ceramide (Fig. 1G). As shown in Table 1, the inhibitory effect of C2-ceramide on BFA-induced Golgi disassembly was concentration-dependent. Essentially the same results were obtained when BHK-21 cells were used instead of NRK cells or when short chain ceramides obtained from different commercial sources were used (data not shown). When NRK cells were incubated with 5 µg/ml BFA for 30 minutes in the presence of 100 µM C6-ceramide, the conditions used by Kok et al. (1998), Golgi disassembly occurred in only a small number of cells (data not shown). At

Fig. 1. Short chain ceramides inhibit BFA-induced Golgi disassembly without affecting the rapid release of β-COP. NRK cells were preincubated at 37°C for 30 minutes in the presence of 0.1% dimethylsulfoxide (DMSO; C and D), 5 µM C6-ceramide (E and F) or 5 µM C2-ceramide (G and H). BFA was added at a final concentration of 10 µM, and the cells were further incubated at 37°C for 6 minutes. After fixation, they were double immunostained with a monoclonal anti-Man II antibody (A,C,E,G) and a polyclonal anti-βCOP antibody (B,D,F,H). Control cells without BFA treatment (A and B). Bar, 20 µm.

Table 1. Effect of C2-ceramide on BFA-induced Golgi disassembly C2-ceramide (µM) 0 1 2 5

Cells with disassembled Golgi apparatus (%) ~100 85 70 7

NRK cells were preincubated at 37°C for 30 minutes in the presence of C2ceramide at the indicated concentrations. BFA was added at a final concentration of 10 µM, and the cells were further incubated at 37°C for 6 minutes. They were immunostained with a monoclonal anti-Man II antibody, and the percentage of cells with disassembled Golgi apparatus was determined. Results are means from three experiments.

Effects of ceramide on the Golgi stability 3301

Short chain ceramides do not block the BFAinduced rapid release of COPI from Golgi membranes Disassembly of the Golgi apparatus by BFA takes place following the rapid release of COPI from the Golgi apparatus (Klausner et al., 1992). This release is due to the inhibitory effect of BFA on the guanine nucleotide exchange factor for ARF1 (Donaldson et al., 1992; Helms and Rothman, 1992). Although C6- and C2-ceramides inhibited redistribution of Man II induced by BFA, they did not prevent the rapid release of βCOP, a component of COPI (Waters et al., 1991), from Golgi membranes (Fig. 1F,H). These results suggest that short chain ceramides inhibit BFA-induced Golgi disassembly without affecting the BFA-induced inhibition of the guanine nucleotide exchange factor for ARF1.

Effects of short chain ceramides on BFA-induced tubulation of the trans-Golgi network (TGN) and endosomes BFA causes not only redistribution of Golgi components into the ER, but also tubulation of the TGN, endosomes, and lysosomes. The tubules from the Golgi and endosomes are fused, whereas the lysosomal tubules remain apart (Lippincott-Schwartz et al., 1991; Wood et al., 1991). We next examined whether or not short chain ceramides suppress the action of BFA on the TGN and endosomes. When cells were preincubated with 10 µM C6-ceramide for 30 minutes, the morphology of the TGN represented by TGN38, a TGN marker protein (Luzio et al., 1990), changed from a ribbonlike structure to dot-like ones without changing the localization (Fig. 2C). Upon incubation with BFA for 6 minutes, no significant morphological change in the TGN38containing dots was observed in the presence of C6-ceramide (Fig. 2D). In the absence of C6-ceramide, as described previously (Lippincott-Schwartz et al., 1991; Wood et al., 1991), TGN38-containing tubules appeared when cells were

Fig. 2. C6-ceramide but not C2-ceramide suppresses BFA-induced tubulation of the TGN. NRK cells were preincubated at 37°C for 30 minutes in the presence of 0.1% DMSO (A and B), 10 µM C6ceramide (C and D) or 10 µM C2-ceramide (E and F). BFA was added at a final concentration of 10 µM, and the cells were further incubated at 37°C for 6 minutes. After fixation, they were immunostained with a monoclonal anti-TGN38 antibody. Cells before (A,C,E) and after (B,D,F) BFA treatment. Bar, 20 µm.

Fig. 3. Short chain ceramides do not inhibit BFA-induced tubulation of recycling endosomes. NRK cells were preincubated in the absence of fetal calf serum at 37°C for 1 hour. To the medium was added 25 µg/ml fluorescein-conjugated Tf, and the incubation was continued for another 1 hour in the presence of 0.1% DMSO (A and B), 10 µM C6-ceramide (C and D) or 10 µM C2-ceramide (E and F). BFA was added at a final concentration of 10 µM, and the cells were further incubated at 37°C for 6 minutes. After fixation, they were immunostained with a polyclonal anti-Tf antibody. Cells before (A,C,E) and after (B,D,F) BFA treatment. Bar, 20 µm.

present we cannot reconcile our results with those of Kok et al. (1998). However, the following results clearly showed that ceramides are closely related to the stability of the Golgi apparatus.

3302 T. Fukunaga and others incubated with BFA (Fig. 2B). In the case of C2-ceramide, fragmentation of the TGN occurred (Fig. 2E), but BFAinduced tubulation was not significantly suppressed (Fig. 2F). To examine the effects of short chain ceramides on BFAinduced tubulation of recycling endosomes, we investigated the morphology of recycling endosomes containing Tf. For this purpose, cells were preincubated with 25 µg/ml fluorescein-conjugated Tf in the presence or absence of 10 µM C6- or C2-ceramide for 1 hour, and then treated with BFA for 6 minutes. Since the fluorescence intensity of fluoresceinconjugated Tf was weak, cells were further immunostained with an anti-Tf antibody followed by a fluorescein isothiocyanate-labeled secondary antibody. Despite a partial inhibition of Tf recycling by C6-ceramide (Chen et al., 1995), Tf was uptaken by cells into endosomes, and the patterns of Tf staining were not significantly different between control cells (Fig. 3A) and short chain ceramide-treated cells (Fig. 3C, E). Neither C6-ceramide (Fig. 3D) nor C2-ceramide (Fig. 3F) prevented BFA-induced tubulation of recycling endosomes. Electron microscopic analysis of C6-ceramidetreated cells To confirm the immunofluorescence observations, we performed electron microscopic analysis of C6-ceramidetreated NRK cells. In agreement with a previous observation (Linardic et al., 1996), the distal Golgi region was apparently dilated (Fig. 4B), but the nuclear envelope and ER remained intact. This structural change may be relevant to the morphological change in the TGN38-containing compartment (Fig. 2). As well as this effect, C6ceramide caused the formation of large distended saccules, often containing other membrane-bound structures within them, as reported previously (Rosenwald and Pagano, 1993b). In addition, it produced membrane aggregates located close to the Golgi region. Consistent with the immunofluorescence observations (Fig. 1), BFA-induced Golgi disassembly did not occur when cells were incubated with C6-ceramide (Fig. 4D). Interestingly, the distended saccules disappeared during BFA treatment, but we did not further examine this phenomenon. Fig. 4. Analysis of C6-ceramide-treated cells by electron microscopy. NRK cells were preincubated at 37°C for 30 minutes in the presence of 0.1% DMSO (A and C) or 10 µM C6-ceramide (B and D). BFA was added at a final concentration of 10 µM, and the cells were further incubated at 37°C for 6 minutes (C and D). Representative Golgi apparatus (G), vesicles (V), saccules (S), nucleus (N) and aggregates (A) are marked. Bar, 1 µm.

Short chain ceramides retard Golgi disassembly induced by NDGA and nocodazole To examine whether or not short chain ceramides generally stabilize the Golgi apparatus, we used other compounds that are known to cause Golgi disassembly in mechanisms different from that of BFA. We and others previously showed that NDGA causes Golgi disassembly without affecting the attachment of COPI to Golgi membranes (Yamaguchi et al., 1997; Drecktrah et al., 1998; Fujiwara et al., 1998). When cells were preincubated with 10 µM C2ceramide for 30 minutes, NDGA-induced Golgi disassembly was markedly prevented (Fig. 5C). C6-ceramide at the same concentration had a similar but lesser effect. Golgi membranes became fragmented but not completely vesiculated (Fig. 5B). Nocodazole causes depolymerization of microtubules (Zieve et al., 1980), leading to Golgi disassembly (Rogalski and Singer, 1984). Recent studies suggest that this compound promotes redistribution of Golgi components into the ER, and the redistributed components may coalesce at or about ER exit sites to regenerate Golgi mini-stacks (Cole et al., 1996; Storrie et al., 1998; Drecktrah and Brown, 1999). When cells were preincubated with short chain ceramides for 30 minutes followed by incubation with 15 µg/ml nocodazole for 90 minutes Golgi dispersion was considerably blocked. In this case, 5 µM C6-ceramide had a more significant effect (Fig. 6C) than 5 µM C2-ceramide (Fig. 6D). Neither ceramide significantly affected microtubule disassembly by nocodazole (data not shown).

Effects of ceramide on the Golgi stability 3303 with 10 µM BFA for 3 minutes, surprisingly, Man II staining became disperse in almost all sphingomyelinase-treated cells (Fig. 7D). On the other hand, Golgi dispersion occurred in about 70% of control cells. These results raised the possibility that endogenously formed ceramides stimulate BFA-induced Golgi disassembly. It should be noted, however, that BFAinduced Golgi disassembly was still inhibited by C6-ceramide (Fig. 7E) or C2-ceramide (Fig. 7F) even after cells had been treated with sphingomyelinase. We carried out a similar experiment except that the incubation time with BFA was 2 minutes because no significant Golgi dispersion occurred in control cells during this short incubation. Under this condition, Golgi disassembly occurred in about 60% of sphingomyelinase-treated cells. These experiments were repeated several times and essentially the same results were obtained each time.

Fig. 5. Short chain ceramides inhibit NDGA-induced Golgi disassembly. NRK cells were preincubated at 37°C for 30 minutes in the presence of 0.1% DMSO (A), 10 µM C6-ceramide (B) or 10 µM C2-ceramide (C). NDGA was added at a final concentration of 20 µM, and the cells were further incubated at 37°C for 15 minutes. After fixation, they were immunostained with a monoclonal antiMan II antibody. Bar, 20 µm.

Sphingomyelinase treatment enhances the action of BFA The results described above raise the possibility that ceramide stabilizes the Golgi apparatus. We next examined whether ceramide generation inside cells also suppresses BFA-induced Golgi disassembly. For this purpose, cells were preincubated for 1 hour with 500 mU/ml sphingomyelinase. Previous studies showed that treatment of cells with 1 U/ml sphingomyelinase for 1 hour increases ceramide levels 2- to 4-fold over control levels (Kolesnick, 1989; Olivera et al., 1992; Oda et al., 1995). The incubation of cells with sphingomyelinase caused a slight fragmentation of the Golgi apparatus, represented by Man II staining (Fig. 7C). When the resultant cells were incubated

Inhibitors of sphingolipid biosynthesis affect the action of BFA To confirm that the accumulation of endogenous ceramides enhances the action of BFA, we used two metabolic inhibitors of sphingolipid biosynthesis, NOE and PDMP. NOE inhibits ceramidase, the enzyme that mediates the conversion of ceramide to sphingosine (Sugita et al., 1975). PDMP is an inhibitor for the synthesis of glucosylceramide and sphingomyelin from ceramide (Radin et al., 1993). Ceramide levels are known to increase 2- to 2.5-fold by treatment of cells with NOE (Wiesner and Dawson, 1996; Spinedi et al., 1999) or PDMP (Maceyka and Machamer, 1997). When cells were preincubated without or with 20 µM NOE for 2 hours, and then treated with 10 µM BFA for 2 minutes, dispersed staining patterns for Man II were observed in many NOE-treated cells (Fig. 8D), whereas no significant Man II dispersion occurred in control cells (Fig. 8B). To examine the effect of PDMP, cells were preincubated with 70 µM PDMP for 1 minute or 2 hours, and then treated with 10 µM BFA for 2 minutes. In this experiment, PDMP was omitted during incubation with BFA because Kok et al. (1998) previously reported that PDMP inhibits BFA-induced Golgi disassembly by perturbing calcium homeostasis. This inhibitory effect was reversible, and was not observed when PDMP was omitted during incubation with BFA (T. Fukunaga and M. Tagaya, unpublished results). As shown in Fig. 9, preincubation of cells with PDMP for 2 hours significantly enhanced BFA-induced Golgi disassembly, whereas preincubation for 1 minute had essentially no effect. The requirement of a long time incubation with PDMP for the stimulation of the action of BFA may reflect a gradual accumulation of endogenous ceramides in the presence of PDMP. Effects of D-erythro-C16-ceramide on the action of BFA To test more directly that natural long chain ceramides enhance the action of BFA on the Golgi apparatus, D-erythro-C16ceramide, an abundant species of endogenous ceramides, was dissolved in ethanol/dodecane, and then added to cells. Under these conditions, long chain ceramides can be incorporated into cells (Ji et al., 1995). When cells were preincubated with 25 µg/ml D-erythro-C16ceramide for 1 hour, the Golgi apparatus became slightly

3304 T. Fukunaga and others

Fig. 6. Short chain ceramides retard nocodazole-induced Golgi disassembly. NRK cells were preincubated at 37°C for 30 minutes in the presence of 0.1% DMSO (B), 10 µM C6-ceramide (C) or 10 µM C2ceramide (D). Nocodazole was added at a final concentration of 15 µg/ml, and the cells were further incubated at 37°C for 90 minutes. After fixation, they were immunostained with a monoclonal antiMan II antibody. Control cells (A). Bar, 20 µm.

fragmented (Fig. 10C), as observed for sphingomyelinase-treated cells (Fig. 7). Incubation of the cells with 10 µM BFA for 2 minutes caused a significant Golgi dispersion (Fig. 10D), whereas no significant Golgi dispersion occurred in cells preincubated with ethanol/dodecane alone (Fig. 10B). Similar results were obtained when natural ceramides from bovine brain were used (data not shown). It should be noted that C6-ceramide (Fig. 10E) and C2-ceramide (Fig. 10F) inhibited BFA-induced Golgi disassembly even in the presence of D-erythro-C16-ceramide. DISCUSSION

Fig. 7. Sphingomyelinase treatment enhances BFA-induced Golgi disassembly. Cells were preincubated at 37°C for 1 hour without (A and B) or with 500 mU/ml sphingomyelinase (C and D), 500 mU/ml sphingomyelinase plus 10 µM C6-ceramide (E) or 500 mU/ml sphingomyelinase plus 10 µM C2-ceramide (F). BFA was added at a final concentration of 10 µM, and the cells were further incubated at 37°C for 3 minutes. After fixation, they were immunostained with a monoclonal anti-Man II antibody. Cells before (A and C) and after (B,D,E,F) BFA treatment. Bar, 20 µm.

In the present study we examined the effects of short chain and long chain ceramides on the stability of the Golgi apparatus. We found that exogenously added short chain ceramides markedly inhibit BFA-induced Golgi disassembly without affecting the rapid release of COPI from Golgi membranes. Short chain ceramides also retarded Golgi disassembly induced by NDGA and nocodazole, suggesting that they stabilize the Golgi apparatus. On the other hand, natural long chain ceramides enhanced BFA-induced Golgi disassembly. These results, in conjunction with the previous finding that short chain ceramide inhibits protein traffic through the Golgi apparatus (Rosenwald and Pagano, 1993b), suggest that the effect of ceramides on the properties of Golgi membranes is a general one. The observation that short chain and natural long chain ceramides have different effects on membrane dynamics is not peculiar to the present case. Accumulation of long chain ceramides by PDMP causes early Golgi resident proteins such as ERGIC-53 to be redistributed into the ER, whereas exogenously added short chain ceramide does not show the same effect (Maceyka and Machamer, 1997). In addition, short chain ceramide partially inhibits the endocytic pathways (Chen

Effects of ceramide on the Golgi stability 3305

Fig. 8. NOE stimulates BFA-induced Golgi disassembly. Cells were preincubated without (A and B) or with 20 µM NOE (C and D) at 37°C for 2 hours. BFA was added at a final concentration of 10 µM, and the cells were further incubated at 37°C for 2 minutes. After fixation, they were immunostained with a monoclonal antiMan II antibody. Cells before (A and C) and after (B and D) BFA treatment. Bar, 20 µm.

et al., 1995; Li et al., 1999), whereas the formation of long chain ceramides by sphingomyelinase treatment rather promotes the ATP-independent formation of endocytic vesicles (Zha et al., 1998). It appears that short chain ceramide inhibits the formation of vesicles and/or tubules from membranes, whereas long chain ceramide enhances it. How does ceramide affect the Golgi structure? One possibility is that ceramide modulates the activities of proteins involved in the organization of the Golgi apparatus by phosphorylation and dephosphorylation. It is well known that ceramides activate several kinases (Westwick et al., 1995; Zhang et al., 1997) and a phosphatase (Dobrowsky and Hannun, 1992) in a species-dependent manner (Wolff et al., 1994). Previous studies showed that the process of vesicular transport is regulated by phosphorylation and dephosphorylation (Davidson et al., 1992; Jamora et al., 1999), and accumulating bodies of evidence suggest that the mechanism of the organization of the Golgi apparatus is quite similar to that of vesicular transport (Warren and Malhotra, 1998). An alternative possibility is that ceramide affects the physical properties of the Golgi apparatus. Natural long chain ceramides, like diacylglycerol, are known to mix poorly with phospholipids in bilayers and facilitate the formation of

Fig. 9. PDMP stimulates BFA-induced Golgi disassembly. Cells were preincubated at 37°C without (A) or with 70 µM PDMP for 1 minute (B) or 2 hours (C). BFA was added at a final concentration of 10 µM, and the cells were further incubated at 37°C for 2 minutes. After fixation, they were immunostained with a monoclonal anti-Man II antibody. Bar, 20 µm.

inverted hexagonal phases, thereby causing destabilization of phospholipid membranes (Veiga et al., 1999). At preset we favor the latter possibility because in a similar fashion short chain ceramides affect Golgi disassembly that occurs through different mechanisms. Perhaps the different effects of C6- and C2-ceramides on different Golgi-disrupting reagents are due to the different physicochemical properties of these ceramides. Recent studies clearly demonstrated the importance of the lipid structure for the formation of transport vesicles (Zha et al., 1998; Schmidt et al., 1999; Weigert et al., 1999). Conversion of lysophosphatidic acid, an inverted cone-shaped lipid, to phosphatidic acid, a cone-shaped lipid, induces fission of membranes from the Golgi (Weigert et al., 1999) and plasma membrane (Schmidt et al., 1999). Since natural long chain ceramide does not have a bulky polar head group, it should be a cone-shaped lipid as phosphatidic acid. On the contrary, short chain ceramide is perhaps a cylindrical or inverted cone-shaped lipid because the length of the acyl group at sn-2 position is short. The presence of the cylindrical or inverted cone-shaped lipid at a high amount in Golgi membranes may inhibit the formation of tubules and/or vesicles, thereby inhibiting Golgi disassembly as well as protein traffic through the Golgi apparatus (Rosenwald and Pagano, 1993b). In contrast,

3306 T. Fukunaga and others

Fig. 10. Effect of D-erythro-C16-ceramide on BFA-induced Golgi disassembly. Cells were preincubated at 37°C for 1 hour with ethanol/dodecane alone (A and B) or with 25 µg/ml D-erythro-C16-ceramide (C and D), 25 µg/ml D-erythro-C16-ceramide plus 10 µM C6-ceramide (E) or 25 µg/ml D-erythro-C16ceramide plus 10 µM C2-ceramide (F). BFA was added at a final concentration of 10 µM, and the cells were further incubated at 37°C for 2 minutes. After fixation, they were immunostained with a monoclonal anti-Man II antibody. Cells before (A and C) and after (B,D,E,F) BFA treatment. Bar, 20 µm.

accumulation of natural long chain ceramides, cone-shaped lipids, may facilitate the formation of tubules and/or vesicles and cause the destabilization of the Golgi apparatus. In this context, it should be noted that short chain ceramides still inhibit BFA-induced Golgi disassembly even when the levels of long chain ceramides are increased. The quantitative balance between long chain and short chain ceramides may be crucial for the stability of the Golgi apparatus. Although our results clearly demonstrated that short chain ceramides stabilize the Golgi apparatus, it should be noted that they are not normally present in cells. Therefore, the effect of long chain ceramides may be of physiological significance. Interestingly, ceramide levels are known to change during cell cycle progression. They are similar in G1, S, and G2 phases, but increase during mitosis (Yokoyama et al., 1997; Lee et al., 1998). The increase in ceramide levels during mitosis may be related to the fact that the Golgi apparatus is disassembled at the onset of mitosis. This work was supported in part by Grants-in-Aid (#10215205 and #11480183) from the Ministry of Education, Science, Sports and Culture of Japan, and by the Naito Foundation and the Uehara Memorial Foundation. We thank Ms A. Ikegami and Mr K. Yoshida for their technical assistance. We also thank Dr T. Yamaguchi for the generous gift of anti-β-COP.

REFERENCES Chen, C.-S., Rosenwald, A. G. and Pagano, R. E. (1995). Ceramide as a modulator of endocytosis. J. Biol. Chem. 270, 13291-13297. Cole, N. B., Sciaky, N., Marotta, A., Song, J. and Lippincott-Scwartz, J. (1996). Golgi dispersal during microtubule disruption: regeneration of Golgi stacks at peripheral endoplasmic reticulum exit sites. Mol. Biol. Cell 7, 631650. Davidson, H. W., McGowan, C. H. and Balch, W. E. (1992). Evidence for the regulation of exocytic transport by protein phosphorylation. J. Cell Biol. 116, 1343-1355. Dobrowsky, R. T. and Hannun, Y. A. (1992). Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 267, 5048-5051. Donaldson, J. G., Finazzi, D. and Klausner, R. D. (1992). Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein. Nature 360, 350-352. Drecktrah, D., de Figueiredo, P., Mason, R. M. and Brown, W. J. (1998). Retrograde trafficking of both Golgi complex and TGN markers to the ER induced by nordihydroguaiaretic acid and cyclofenil diphenol. J. Cell Sci. 111, 951-965. Drecktrah, D. and Brown, W. J. (1999). Phospholipase A2 antagonists inhibit nocodazole-induced Golgi ministack formation: evidence of an ER intermediate and constitutive cycling. Mol. Biol. Cell 10, 4021-4032. Fujiwara, T., Takami, N., Misumi, Y. and Ikehara, Y. (1998). Nordihydroguaiaretic acid blocks protein transport in the secretory pathway causing redistribution of Golgi proteins into the endoplasmic reticulum. J. Biol. Chem. 273, 3068-3075. Fukasawa, M., Nishijima, M. and Hanada, K. (1999). Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of

Effects of ceramide on the Golgi stability 3307 ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. J. Cell Biol. 144, 673-685. Fukunaga, T., Furuno, A., Hatsuzawa, K., Tani, K., Yamamoto, A. and Tagaya, M. (1998). NSF is required for the brefeldin A-promoted disassembly of the Golgi apparatus. FEBS Lett. 435, 237-240. Hannun, Y. A. (1994). The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269, 3125-3128. Helms, J. B. and Rothman, J. E. (1992). Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature 360, 352-354. Hoekstra, D. and Kok, J. W. (1992). Trafficking of glycosphingolipids in eukaryotic cells: sorting and recycling of lipids. Biochim. Biophys. Acta 1113, 277-294. Jamora, C., Yamanouye, N., Van Lint, J., Laudenslager, J., Vandenheede, J. R., Faulkner, D. J. and Malhotra, V. (1999). Gβγ-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell 98, 59-68. Ji, L., Zhang, G., Uematsu, S., Akahori, Y. and Hirabayashi, Y. (1995). Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358, 211-214. Klausner, R. D., Donaldson, J. G. and Lippincott-Schwartz, J. (1992). Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 116, 1071-1080. Kok, J. W., Babia, T., Filipeanu, C. M., Nelemans, A., Egea, G. and Hoekstra, D. (1998). PDMP blocks brefeldin A-induced retrograde membrane transport from Golgi to ER: evidence for involvement of calcium homeostasis and dissociation from sphingolipid metabolism. J. Cell Biol. 142, 25-38. Kolesnick, R. N. (1989). Sphingomyelinase action inhibits phorbol esterinduced differentiation of human promyelocytic leukemic (HL-60) cells. J. Biol. Chem. 264, 7617-7623. Kolesnick, R. N. and Kronke, M. (1998). Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60, 643-665. Kornfeld, R. and Kornfeld, S. (1985). Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54, 631-664. Lee, J. Y., Leonhardt, L. G. and Obeid, L. M. (1998). Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M. Biochem. J. 334, 457-461. Li, R., Blanchette-Mackie, E. J. and Ladisch, S. (1999). Induction of endocytic vesicles by exogenous C6-ceramide. J. Biol. Chem. 274, 21121-21127. Linardic, C. M., Jayadev, S. and Hannun, Y. A. (1996). Activation of the sphingomyelin cycle by brefeldin A: effects of brefeldin A on differentiation and implications for a role for ceramide in regulation of protein trafficking. Cell Growth Differ. 7, 765-774. Lippincott-Schwartz, J., Yuan, L., Tipper, C., Amherdt, M., Orci, L. and Klausner, R. D. (1991). Brefeldin A’s effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67, 601-616. Lipsky, N. G. and Pagano, R. E. (1985). A vital stain for the Golgi apparatus. Science 228, 745-747. Luzio, J. P., Brake, B., Banting, G., Howell, K. E., Braghetta, P. and Stanley, K. K. (1990). Identification, sequencing and expression of an integral membrane protein of the trans-Golgi network (TGN38). Biochem. J. 270, 97-102. Maceyka, M. and Machamer, C. E. (1997). Ceramide accumulation uncovers a cycling pathway for the cis-Golgi network marker, infectious bronchitis virus M protein. J. Cell Biol. 139, 1411-1418. Oda, T., Chen, C.-H. and Wu, H. C. (1995). Ceramide reverses brefeldin A (BFA) resistance in BFA-resistant Cell Lines. J. Biol. Chem. 270, 4088-4092. Olivera, A., Buckley, N. E. and Spiegel, S. (1992). Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J. Biol. Chem. 267, 26121-26127. Radin, N. S., Shayman, J. A. and Inokuchi, J. (1993). Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv. Lipid Res. 26, 183-213. Rogalski, A. A. and Singer, S. J. (1984). Associations of elements of the Golgi apparatus with microtubules. J. Cell Biol. 99, 1092-1100. Rosenwald, A. G. and Pagano, R. E. (1993a). Intracellular transport of ceramide and its metabolites at the Golgi complex: insights from short-chain analogs. Adv. Lipid Res. 26, 101-118. Rosenwald, A. G. and Pagano, R. E. (1993b). Inhibition of glycoprotein traffic through the secretory pathway by ceramide. J. Biol. Chem. 268, 45774579. Schmidt, A., Wolde, M., Thiele, C., Fest, W., Kratzin, H., Podtelejnikov,

A. V., Witke, W., Huttner, W. B. and Söling, H. D. (1999). Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid. Nature 401, 133-141. Shinkai, M., Takeyama, Y., Ueda, T., Hori, Y. and Yamamoto, M. (1997). Inhibitory action of sphingosine or ceramide on amylase secretion from isolated rat pancreatic acini. Biochem. Biophys. Res. Commun. 235, 197200. Spanfo, S., Silletta, M. G., Colanzi, A., Alberti, S., Fiucci, G., Valente, C., Fusella, A., Salmona, M., Mironov, A., Luini, A. and Corda, D. (1999). Molecular Cloning and functional characterization of brefeldin A-ADPribosylated substrate. J. Biol. Chem. 274, 17705-17710. Spinedi, A., Di Bartolomeo, S. and Piacentini, M. (1999). N-oleoylethanolamine inhibits glucosylation of natural ceramides in CHP-100 neuroepithelioma cells: possible implications for apoptosis. Biochem. Biophys. Res. Commun. 255, 456-459. Storrie, B., White, J., Röttger, S., Stelzer, E. H. K., Suganuma, T. and Nilson, T. (1998). Recycling of Golgi-resident glycosyltransferases through the ER reveals a novel pathway and provides an explanation for nocodazoleinduced Golgi scattering. J. Cell Biol. 143, 1505-1521. Sugita, M., Williams, M., Dulaney, J. T. and Moser, H. W. (1975). Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase. Biochim. Biophys. Acta 398, 125-131 Tagaya, M., Furuno, A. and Mizushima, S. (1996). SNAP prevents Mg2+ATP-induced release of N-ethylmaleimide-sensitive factor from the Golgi apparatus in digitonin-permeabilized PC12 cells. J. Biol. Chem. 271, 466470. van Meer, G. (1993). Transport and sorting of membrane lipids. Curr. Opin. Cell Biol. 5, 661-673. Veiga, M. P., Arrondo, J. L. R., Gõni, F. M. and Alonso, A. (1999). Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. Biophy. J. 76, 342-350. Warren, G. and Malhotra, V. (1998). The organisation of the Golgi apparatus. Curr. Opin. Cell Biol. 10, 493-498. Waters, M. G., Serafini, T. and Rothman, J. E. (1991). ‘Coatomer’: a cytosolic protein complex containing subunits of non-clathrin-coated Golgi transport vesicles. Nature 349, 248-251. Weigert, R., Silletta, M. G., Spano, S., Turacchio, G., Cericola, C., Colanzi, A., Senatore, S., Mancini, R., Polishchuk, E. V., Salmona, M., Facchiano, F., Burger, K. N. J., Mironov, A., Luini, A. and Corda, D. (1999). CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid. Nature 402, 429-433. Westwick, J. K., Bielawska, A. E., Dbaibo, G., Hannun, Y. A. and Brenner, D. A. (1995). Ceramide activates the stress-activated protein kinases J. Biol. Chem. 270, 22689-22692. Wiesner, D. A. and Dawson, G. (1996). Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J. Neurochem. 66, 1418-1425. Wood, S. A., Park, J. E. and Brown, W. J. (1991). Brefeldin A causes a microtubule-mediated fusion of the trans-Golgi network and early endosomes. Cell 67, 591-600. Wolff, R. A., Dobrowsky, R. T., Bielawska, A., Obeid, L. M. and Hannun, Y. A. (1994). Role of ceramide-activated protein phosphatase in ceramidemediated signal transduction. J. Biol. Chem. 269, 19605-19609. Yamaguchi, T., Yamamoto, A., Furuno, A., Hatsuzawa, K., Tani, K., Himeno, M. and Tagaya, M. (1997). Possible involvement of heterotrimeric G proteins in the organization of the Golgi apparatus. J. Biol. Chem. 272, 25260-25266. Yokoyama, K., Suzuki, M., Kawashima, I., Karasawa, K., Nojima, S., Enomoto, T., Tai, T., Suzuki, A. and Setaka, M. (1997). Changes in composition of newly synthesized sphingolipids of HeLa cells during the cell cycle: suppression of sphingomyelin and higher-glycosphingolipid synthesis and accumulation of ceramide and glucosylceramide in mitotic cells. Eur. J. Biochem. 249, 450-455. Zha, X., Pierini, L. M., Leopold, P. L., Skiba, P. J., Tabas, I. and Maxfield, F. R. (1998). Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell Biol. 140, 39-47. Zhang, Y., Yao, B., Delikat, S., Bayoumy, S., Lin, X.-H., Basu, S., McGinley, M., Chan-Hui, P.-Y., Lichenstein, H. and Kolesnick, R. (1997). Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89, 63-72. Zieve, G. W., Turnbull, D., Mullins, J. M. and McIntosh, J. R. (1980). Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Exp. Cell Res. 126, 397-405.